BANDARAM PHARMA PACKTECH LIMITED

BSE: BANDARAM524602ISIN INE875N01036

Healthcare
Healthcare Service Provider

Share price

₹19.03+0.03 (+0.16%)

as of 4 Nov 2026

Prices adjusted for splits and bonuses; cash dividends excluded. Volume shows actual shares traded.

52W high: ₹49.70
52W low: ₹17.25
Off 52W high: -61.71%
1M return: -0.31%
3M return: -3.35%
6M return: -24.33%
1Y return: -22.14%
20D avg volume: 2,271
50 DMA: ₹19.61
200 DMA: ₹24.75

Key ratios Consolidated

Market cap: ₹34.20 Cr
Current price: ₹19.03
52W high / low: ₹49.70 / ₹17.25
Face value: ₹10.00
P/E: 25.81
P/B: 1.28
EPS (TTM): ₹0.74
Book value / share: ₹14.88
ROE: —
ROCE: 4.70%
Operating margin: —
Net margin: —
Debt / equity: 0.76
Net debt: ₹23.22 Cr
Interest cover: 1.29
Dividend yield: —
Dividend / share (TTM): —
Payout: —
Cash conversion cycle: 162.7 days

Financials

Metric	Q2 FY27	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24
Income statement
	21.45	23.95	26.26	14.84	13.72	8.10	8.49	10.00	7.11	11.37	—
	0.00	0.00	0.01	0.00	0.01	0.00	0.09	0.00	0.00	0.00	—
	21.45	23.95	26.27	14.84	13.73	8.10	8.59	10.00	7.11	11.37	—
	21.03	23.03	26.13	14.31	13.66	8.07	8.38	9.73	6.44	11.19	—
	18.60	21.61	23.13	14.02	10.89	6.48	4.38	8.12	5.17	13.29	—
	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—	—
	0.71	0.73	2.25	0.58	0.53	0.55	1.08	0.59	0.69	0.59	—
	0.48	0.42	0.46	0.33	0.25	0.46	-0.10	0.24	0.26	0.21	—
	0.25	0.20	0.25	0.14	0.14	0.13	0.53	0.15	0.15	0.15	—
	0.85	0.92	1.14	0.67	0.43	0.51	0.32	0.36	0.41	0.44	—
	0.42	0.93	0.14	0.53	0.08	0.04	0.20	0.27	0.67	0.18	—
	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—
	0.42	0.93	0.14	0.53	0.08	0.04	0.20	0.27	0.67	0.18	—
	0.24	0.24	0.03	0.18	0.02	0.01	0.04	0.28	0.00	0.00	—
	0.19	0.68	0.11	0.35	0.06	0.03	0.16	-0.01	0.67	0.18	—
	-0.12	0.11	0.06	0.11	0.03	0.01	0.13	-0.01	0.56	0.15	—
Key metrics
	1.15	1.55	0.85	1.00	0.47	0.63	0.63	0.66	1.08	0.54	—
	5.40%	6.50%	3.20%	6.70%	3.40%	7.80%	7.40%	6.60%	15.20%	4.70%	—
	0.90%	2.80%	0.40%	2.40%	0.40%	0.40%	1.90%	-0.10%	9.40%	1.60%	—
	2.10%	—	1.40%	—	1.30%	—	0.40%	—	—	—	—
	56.30%	195.70%	209.30%	48.40%	93.00%	-28.80%	—	—	—	—	—
	216.70%	2,166.70%	-31.20%	3,600.00%	-91.00%	-83.30%	—	—	—	—	—

Metric	TTM	FY26	FY25	FY24
Income statement
	86.50	62.92	36.96	—
	0.01	0.02	0.09	—
	86.51	62.94	37.06	—
	84.50	62.50	35.74	—
	77.36	55.02	30.96	—
	0.00	0.00	0.00	—
	4.27	3.91	2.96	—
	1.69	1.51	0.61	—
	0.84	0.97	0.99	—
	3.58	2.26	1.53	—
	2.02	0.44	1.32	—
	0.00	0.00	0.00	—
	2.02	0.44	1.32	—
	0.69	0.16	0.32	—
	1.33	0.28	0.99	—
	0.16	0.83	0.83	—
Key metrics
	4.55	2.92	2.92	—
	5.26%	4.60%	7.90%	—
	1.54%	0.40%	2.70%	—
	—	4.70%	7.80%	—
	114.59%	70.20%	—	—
	454.17%	-71.70%	—	—
	—	-4.92	-5.01	—
	—	-17.57	-4.98	—
	—	0.76	1.08	—
	—	23.22	17.03	—
	—	162.7	226.2	—
Balance sheet
	—	75.86	38.92	—
	—	56.99	30.88	—
	—	0.72	0.12	—
	—	31.35	18.76	—
	—	12.94	8.51	—
	—	3.59	0.00	—
	—	9.41	3.95	—
	—	16.26	4.36	—
	—	34.33	14.03	—
	—	23.94	17.15	—
	—	13.89	8.16	—
	—	10.05	8.99	—
	—	31.37	15.82	—
Cash flow
	—	-4.92	-4.93	—
	—	0.00	-0.08	—
	—	5.53	5.09	—
	—	0.00	0.08	—

Metric	Q2 FY27	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24
Income statement
	2.37	2.99	8.20	1.68	0.33	0.76	3.71	2.63	3.17	2.72	—
	0.00	0.00	0.00	0.00	0.01	0.00	0.09	—	—	—	—
	2.37	2.99	8.20	1.68	0.34	0.76	3.80	2.63	3.17	2.72	—
	2.78	3.34	8.53	1.89	0.69	1.03	3.75	2.58	2.83	2.97	—
	2.13	2.76	7.86	1.66	0.33	0.80	3.11	2.38	2.26	2.69	—
	0.00	0.00	0.00	0.00	0.00	-0.04	0.00	—	—	—	—
	0.29	0.28	0.55	0.11	0.11	0.11	0.45	0.16	0.31	0.17	—
	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—	—
	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—
	0.36	0.30	0.12	0.11	0.25	0.16	0.18	0.04	0.27	0.10	—
	-0.41	-0.36	-0.33	-0.21	-0.35	-0.27	0.06	0.05	0.33	-0.25	—
	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—	—
	-0.41	-0.36	-0.33	-0.21	-0.35	-0.27	0.06	0.05	0.33	-0.25	—
	0.00	0.00	0.00	0.00	0.00	0.00	0.01	0.03	—	—	—
	-0.41	-0.36	-0.33	-0.21	-0.35	-0.27	0.04	0.01	0.33	-0.25	—
	-0.23	0.20	-0.18	-0.12	-0.29	-0.22	0.04	0.01	0.28	-0.21	—
Key metrics
	-0.41	-0.36	-0.33	-0.21	-0.35	-0.27	0.06	0.05	0.33	-0.25	—
	-17.30%	-12.00%	-4.00%	-12.50%	-106.10%	-35.50%	1.60%	1.90%	10.40%	-9.20%	—
	-17.30%	-12.00%	-4.00%	-12.50%	-106.10%	-35.50%	1.10%	0.40%	10.40%	-9.20%	—
	-1.50%	—	-1.20%	—	-2.30%	—	0.40%	—	—	—	—
	618.20%	293.40%	121.00%	-36.10%	-89.60%	-72.10%	—	—	—	—	—
	-17.10%	-33.30%	-925.00%	-2,200.00%	-206.10%	-8.00%	—	—	—	—	—

Metric	TTM	FY26	FY25	FY24
Income statement
	15.24	10.96	12.23	—
	0.00	0.01	0.09	—
	15.24	10.97	12.32	—
	16.54	12.13	12.14	—
	14.41	10.60	10.44	—
	0.00	0.00	0.00	—
	1.23	0.88	1.10	—
	0.00	0.00	0.00	—
	0.00	0.00	0.01	—
	0.89	0.64	0.59	—
	-1.31	-1.16	0.19	—
	0.00	0.00	0.00	—
	-1.31	-1.16	0.19	—
	0.00	0.00	0.05	—
	-1.31	-1.16	0.14	—
	-0.33	-0.64	0.12	—
Key metrics
	-1.31	-1.16	0.20	—
	-8.60%	-10.60%	1.60%	—
	-8.60%	-10.60%	1.10%	—
	—	-4.20%	1.20%	—
	105.11%	-10.40%	—	—
	—	-928.60%	—	—
	—	-0.79	-3.25	—
	—	-1.04	-23.21	—
	—	0.20	0.29	—
	—	4.25	3.46	—
	—	134.9	157.6	—
Balance sheet
	—	36.61	19.21	—
	—	15.21	12.62	—
	—	0.26	0.02	—
	—	10.67	6.62	—
	—	2.08	1.64	—
	—	1.69	1.58	—
	—	0.00	0.00	—
	—	8.70	2.98	—
	—	9.21	3.62	—
	—	4.51	3.48	—
	—	0.00	0.00	—
	—	4.51	3.48	—
	—	22.89	12.10	—
Cash flow
	—	1.21	-3.25	—
	—	-2.00	0.00	—
	—	1.03	3.23	—
	—	2.00	0.00	—

Compounded growth

Standalone

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Sales YoY (TTM): +105.11%
Profit YoY (TTM): -129.82%

Consolidated

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Sales YoY (TTM): +114.59%
Profit YoY (TTM): +454.17%

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Sep 2026

Promoter holding: 62.67%

Quarter	September 2026	June 2026
Promoter %	62.67%	62.67%

Holder	Type	Holding	Previous	Change
DEEPAK REDDY B	Promoter	35.28%	35.28%	0.00%
BHANDARAM SATHYAVATHI	Promoter	10.46%	10.46%	0.00%
PREM SAI REDDY B	Promoter	10.46%	10.46%	0.00%
SANIVARAPU JHANSI	Public	4.37%	4.37%	0.00%
PRAJITHA BANDARAM	Promoter Group	2.71%	2.71%	0.00%
L LALANTHIKA	Promoter	2.50%	2.50%	0.00%
SREEDAR REDDY G	Public	2.23%	2.23%	0.00%
SANIVARAPU NAVYA REDDY	Public	2.08%	2.08%	0.00%
KOLLI SURYATEJA REDDY .	Public	1.86%	1.86%	0.00%
SAPNAA .	Public	1.64%	1.64%	0.00%
VIVEK SURANA	Public	1.49%	1.49%	0.00%
LAKSHMI PILLA	Public	1.34%	1.34%	0.00%
ANURADHA NANNAPANENI	Public	1.34%	1.34%	0.00%
SAHITHI KOLLI .	Public	1.34%	1.34%	0.00%
AKHIL REDDY SANIVARAPU	Public	1.25%	1.25%	0.00%

Public shareholders are disclosed individually only above 1%.

Peer comparison

Company	Mkt cap (₹ Cr)	Price (₹)	P/E	ROCE	Sales YoY	Profit YoY	1Y return
Dr. Lal Pathlabs Limited	34,056	2,028.95	57.92	25.70%	+16.71% TTM	+8.93% TTM	+28.73%
Vijaya Diagnostic Centre Limited	14,676	1,424.85	72.05	19.20%	+24.48% TTM	+33.96% TTM	+39.02%
Metropolis Healthcare Limited	12,075	582.05	53.57	15.70%	+19.84% TTM	+41.90% TTM	+14.58%
Thyrocare Technologies Limited	7,883	495.25	55.01	33.60%	+21.99% TTM	+13.16% TTM	+9.41%
Nephrocare Health Services Limited	6,242	620.75	48.72	13.70%	—	—	—
SURAKSHA DIAGNOSTIC LIMITED	1,735	333.10	49.46	14.70%	+23.32% TTM	+7.94% TTM	+2.54%
Krsnaa Diagnostics Limited	1,566	482.90	15.97	10.60%	+15.90% TTM	+16.02% TTM	-37.25%
3B BlackBio Dx Limited	1,142	1,330.25	20.29	22.60%	+54.30% TTM	+14.75% TTM	-1.52%
HEALTH X PLATFORM LIMITED	863	271.20	-33.11	—	+28.85% TTM	+82.45% TTM	-8.73%
ONE GLOBAL SERVICE PROVIDER LIMITED S	861	440.70	11.65	65.70%	+161.55% TTM	+178.28% TTM	+21.17%
Gaudium IVF and Women Health Limited	779	107.05	—	23.10%	—	—	—
Aspira Pathlab & Diagnostics Limited S	144	140.35	-318.98	2.90%	+14.50% TTM	-117.58% TTM	+132.68%
Choksi Laboratories Ltd. S	142	203.90	65.77	12.30%	+10.74% TTM	+44.00% TTM	+38.05%
STAR IMAGING AND PATH LAB LIMITED	120	68.90	—	22.60%	—	—	-51.78%
MODERN DIAGNOSTIC & RESEARCH CENTRE LIMITED S	86	57.00	—	11.20%	—	—	—
Sharma East India Hospitals And Res S	34	87.05	24.11	14.20%	+14.13% TTM	-9.85% TTM	-38.28%
BANDARAM PHARMA PACKTECH LIMITED	34	19.03	25.81	4.70%	+114.59% TTM	+454.17% TTM	-22.14%
N.G.Industries Ltd. S	34	100.00	17.39	6.30%	+2.18% TTM	-74.06% TTM	-23.28%
Deccan Health Care Limited	29	12.00	11.40	3.20%	-0.37% TTM	+145.63% TTM	-29.41%
Chennai Meenakshi Multispeciality Hospital Ltd. S	27	36.78	-32.26	-2.80%	+0.08% TTM	+6.59% TTM	-29.27%
SAMSRITA LABS LIMITED	27	11.93	-3.33	-73.40%	—	—	-43.35%
Tejnaksh Healthcare Limited	26	12.83	21.19	5.90%	-12.97% TTM	-33.15% TTM	-27.02%
Transgene Biotek Ltd.	17	2.57	-12.11	-0.50%	-14.81% TTM	-23.85% TTM	-28.21%
Dolphin Medical Services Ltd. S	11	7.11	59.25	0.60%	-1.25% TTM	+700.00% TTM	+246.83%
Looks Health Services Limited S	11	10.08	504.00	0.20%	-41.89% TTM	-57.14% TTM	+101.20%

Filings & corporate actions

Recent announcements

Newspaper Publication of financial results for quater and half-year ended 30.09.202631 Oct 2026 · Company Update / Newspaper Publication
Outcome of Board Meeting held on 29.10.202629 Oct 2026 · Board Meeting / Outcome of Board Meeting
Results for Quater and half- year ended 30.09.202629 Oct 2026 · Result / Financial Results
Bandaram Pharma Packtech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/10/2026 ,inter alia, to consider and approve 1. Un-audited standalone ....23 Oct 2026 · Board Meeting / Board Meeting
Certificate under Regulation 74(5) of SEBI (DP) Regulations,201810 Oct 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Cancellation of Board Meeting to be held on 30.09.202630 Sep 2026 · Company Update / General
Bandaram Pharma Packtech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/09/2026 ,inter alia, to consider and approve Intimation of Board ....26 Sep 2026 · Board Meeting / Board Meeting
Scrutinizer''s Report of the AGM for the FY 2025-2624 Sep 2026 · AGM/EGM / AGM
Proceedings of AGM for the FY 2025-2624 Sep 2026 · AGM/EGM / AGM
Closure of Trading Window22 Sep 2026 · Insider Trading / SAST / Closure of Trading Window
Annual Report for the FY 2025-26.1 Sep 2026 · Others / Reg. 34 (1) Annual Report
Notice of AGM for the FY 2025-26 Scheduled To Be Held on 24.09.2026.1 Sep 2026 · AGM/EGM / AGM
Change in Management13 Aug 2026 · Company Update / Change in Management
Un-Audited Financial Results (Standalone & Consolidated) for Quater ended 30.06.202613 Aug 2026 · Result / Financial Results
Bandaram Pharma Packtech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve 1. Un-Audited standalone ....6 Aug 2026 · Board Meeting / Board Meeting
Certificate under Reg. 74 (5) of Sebi (DP) Regulations, 2018.11 Jul 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Clarification of Price Movement7 Jul 2026 · Company Update / General
The Exchange has sought clarification from Bandaram Pharma Packtech Ltd on July 6, 2026 with reference to significant movement in price, in order to ensure that investors have latest relevant ....6 Jul 2026 · Company Update / Clarification
Closure of Trading Window for Un-audited Financial Results(Standalone & Consolidated) for the Quarter ending June 30,2026.24 Jun 2026 · Insider Trading / SAST / Closure of Trading Window
Receipt of Order11 Jun 2026 · Company Update / General
Resignation of Whole-Time Director of the Company.5 Jun 2026 · Company Update / Resignation of Director
Change in Management30 May 2026 · Company Update / Change in Management
Audited Financial Results for the Quarter and Year ended 31.03.202630 May 2026 · Result / Financial Results
Receipt of order29 May 2026 · Company Update / Award of Order / Receipt of Order
Receipt of order29 May 2026 · Company Update / Award of Order / Receipt of Order
Receipt of Order29 May 2026 · Company Update / Award of Order / Receipt of Order
Annual Secretarial Compliance Report for FY ended 31.03.202626 May 2026 · Company Update / Reg.24(A)-Annual Secretarial Compliance
Bandaram Pharma Packtech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 ,inter alia, to consider and approve Audited Financial ....21 May 2026 · Board Meeting / Board Meeting
Format of the Annual Disclosure to be made by an entity identified as a Large Corporate. <table border=''1px''> <tr> <td>Sr. No.</td> <td>Particulars</td> ....30 Apr 2026 · Others / Format of the Annual Disclosure to be made by an entity identified as a LC : Annexure B2
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. <table border=''1px''><tr> <td>Sr. No.</td> <td>Particulars</td> <td>Details</td> ....30 Apr 2026 · Others / Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
Scrutinizer''s Report for the EGM of the company for the FY 2026-27 held on 27.04.202627 Apr 2026 · AGM/EGM / EGM
Outcome of EGM of the company for FY 2026-27 held on 27.04.202627 Apr 2026 · AGM/EGM / EGM
Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018.11 Apr 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Notice of Extra-Ordinary General Meeting to be held on 27.04.20263 Apr 2026 · AGM/EGM / EGM
Outcome of Board meeting to be held on 03.04.20263 Apr 2026 · Others / Outcome without intimation
Closure of trading window27 Mar 2026 · Insider Trading / SAST / Closure of Trading Window
Newspaper Publication for Unaudited Financial Results for the quarter and nine months ended 31.12.2025.16 Feb 2026 · Company Update / Newspaper Publication
Outcome of Board meeting held on 13.02.202613 Feb 2026 · Board Meeting / Outcome of Board Meeting
Unaudited Financial Results for the quarter and nine months ended 31.12.202513 Feb 2026 · Result / Financial Results
Bandaram Pharma Packtech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2026 ,inter alia, to consider and approve Unaudited financial ....3 Feb 2026 · Board Meeting / Board Meeting

Corporate actions

Purpose	Ex date	Record date	Payment date
Final Dividend - Rs. - 0.1000	22 Sep 2025	22 Sep 2025	—
Final Dividend - Rs. - 0.1000	20 Sep 2024	—	—

Board meetings

29 Oct 2026 Board Meeting - Financial Results
13 Aug 2026 Board Meeting - Financial Results